Explore

High-Yield Dividend Stocks: Enterprise Products Partners and Realty Income Offer Stability in 2026

High-Yield Dividend Stocks: Enterprise Products Partners and Realty Income Offer Stability in 2026

High-Yield Dividend Stocks: Enterprise Products Partners and Realty Income Offer Stability in 2026

Johnson Johnson, Coca-Cola, and Walmart Highlighted as Reliable Dividend Stocks for Long-Term Investment

Johnson Johnson, Coca-Cola, and Walmart Highlighted as Reliable Dividend Stocks for Long-Term Investment

Johnson Johnson, Coca-Cola, and Walmart Highlighted as Reliable Dividend Stocks for Long-Term Investment

McDonald's Stock Declines 21% Despite Positive Sales Growth

McDonald's Stock Declines 21% Despite Positive Sales Growth

McDonald's Stock Declines 21% Despite Positive Sales Growth

Wall Street Analysts Show Optimism for Dividend Stocks Amid Market Uncertainty

Wall Street Analysts Show Optimism for Dividend Stocks Amid Market Uncertainty

Wall Street Analysts Show Optimism for Dividend Stocks Amid Market Uncertainty

Wall Street Anticipates Key Economic Reports and Corporate Earnings Amid Inflation Concerns

Wall Street Anticipates Key Economic Reports and Corporate Earnings Amid Inflation Concerns

Wall Street Anticipates Key Economic Reports and Corporate Earnings Amid Inflation Concerns

Strategies for Recession-Proofing Portfolios for Individuals in Their 30s and 40s

Strategies for Recession-Proofing Portfolios for Individuals in Their 30s and 40s

Strategies for Recession-Proofing Portfolios for Individuals in Their 30s and 40s

Coca-Cola's All-Time High and Dividend Insights

Coca-Cola's All-Time High and Dividend Insights

Coca-Cola's All-Time High and Dividend Insights

Stock Market Faces Key Economic Data and Earnings Reports as August Begins

Stock Market Faces Key Economic Data and Earnings Reports as August Begins

Stock Market Faces Key Economic Data and Earnings Reports as August Begins

J&J’s biotech progress could punish its 2027 profit

J&J’s biotech progress could punish its 2027 profit

Johnson & Johnson (JNJ) just issued one of the weirdest profit warnings in health care. The biotech business decreased its 2026 adjusted earnings guidance to between $10.96 and $11.11 a share, from a range of $11.60 to $11.75. This year, the newly closed acquisition of Firefly Bio and the ...

Realty Income Corp. Stock Declines Amid Market Gains, Earnings Report Anticipated

Realty Income Corp. Stock Declines Amid Market Gains, Earnings Report Anticipated

Realty Income Corp. Stock Declines Amid Market Gains, Earnings Report Anticipated

AI Stocks Rebound as J's Earnings Guidance Cut Raises Concerns

AI Stocks Rebound as J's Earnings Guidance Cut Raises Concerns

AI Stocks Rebound as J's Earnings Guidance Cut Raises Concerns

Johnson Johnson Receives FDA Clearance for Surgical Robot Amidst Revenue Growth

Johnson Johnson Receives FDA Clearance for Surgical Robot Amidst Revenue Growth

Johnson Johnson Receives FDA Clearance for Surgical Robot Amidst Revenue Growth